Antiviral Drugs Global Market Key Developments, Outlook, 2016 Analysis & Forecast to 2022
ReportsWeb.com published “Antiviral Drugs Global Market” from its database. This report Strategic recommendations in key business segments based on the market estimations. This report Supply chain trends mapping the latest technological advancements.
(EMAILWIRE.COM, May 04, 2017 ) According to Publisher, the Global Antiviral market is accounted for $42.65 billion in 2016 and is expected to reach $63.11 billion by 2022 growing at a CAGR of 5.8%. Increased count of people across the globe affecting from influenza, respiratory syncytial virus and epidemic of viral infections had given market a prudential base for the growth. Strong R&D and newer & advance formulations in the antiviral drugs market are expected to drive the market. However, high risk of failure and huge cost of R&D are hampering the market.
For more information about this report: http://www.reportsweb.com/antiviral-drugs-global-market-outlook-2016-2022
HIV antivirals segment among applications is expected to dominate the market due to increase in prevalence of HIV infections, and due to growing awareness among people. Moreover, generic drugs segment is expected to witness lucrative growth over the forecast period on account of favorable government regulations. North American market is expected to dominate the global market. However, Asia Pacific is estimated to be the fastest growing region due to growing economies and increased healthcare expenditure in the region.
Some of the key players of the Antiviral Drugs market include Abbott Laboratories, AbbVie, Inc., Aurobindo Pharma, Bristol-Myers-Squibb, Cipla, Dr. Reddy's Laboratories Ltd., F. Hoffmann-La Roche AG, Gilead Sciences, GlaxoSmithKline plc., Johnson and Johnson, MedImmune/AstraZeneca, Merck & Co., Mylan N.V., Roche Diagnostics, Schering-Plough and Teva Pharmaceutical Industries Ltd.
Applications Covered:
-Hepatitis-B antivirals
-Hepatitis-C antivirals
-Herpes virus
-HIV antivirals
-Influenza
-Other Applications
-Pneumonia
-Flu
End-Users Covered:
-Ambulatory Surgical Centers
-Clinics
-Hospitals
Distribution Channels covered:
-Hospital Pharmacy Store
-Online Pharmacy
-Retail Pharmacy Store
Product Types Covered:
-Generic Drugs
-Branded Drugs
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001716560/sample
Action Mechanisms covered:
-Nucleotide polymerase inhibitor
-Protease inhibitors
-Reverse transcriptase inhibitors
-Other Action Mechanisms
Regions Covered:
-North America
-US
-Canada
-Mexico
-Europe
-Germany
-France
-Italy
-UK
-Spain
-Rest of Europe
-Asia Pacific
-Japan
-China
-India
-Australia
-New Zealand
-Rest of Asia Pacific
-Rest of the World
-Middle East
-Brazil
-Argentina
-South Africa
-Egypt
Company Profiling
12.1 Abbott Laboratories
12.2 AbbVie, Inc.
12.3 Aurobindo Pharma
12.4 Bristol-Myers-Squibb
12.5 Cipla
12.6 Dr. Reddy's Laboratories Ltd
12.7 F. Hoffmann-La Roche AG
12.8 Gilead Sciences
12.9 GlaxoSmithKline plc.
12.10 Johnson and Johnson
12.11 MedImmune/AstraZeneca
12.12 Merck & Co
12.13 Mylan N.V.
12.14 Roche Diagnostics
12.15 Schering-Plough
12.16 Teva Pharmaceutical Industries Ltd.
Inquire before Buying at http://www.reportsweb.com/inquiry&RW0001716560/buying
For more information about this report: http://www.reportsweb.com/antiviral-drugs-global-market-outlook-2016-2022
HIV antivirals segment among applications is expected to dominate the market due to increase in prevalence of HIV infections, and due to growing awareness among people. Moreover, generic drugs segment is expected to witness lucrative growth over the forecast period on account of favorable government regulations. North American market is expected to dominate the global market. However, Asia Pacific is estimated to be the fastest growing region due to growing economies and increased healthcare expenditure in the region.
Some of the key players of the Antiviral Drugs market include Abbott Laboratories, AbbVie, Inc., Aurobindo Pharma, Bristol-Myers-Squibb, Cipla, Dr. Reddy's Laboratories Ltd., F. Hoffmann-La Roche AG, Gilead Sciences, GlaxoSmithKline plc., Johnson and Johnson, MedImmune/AstraZeneca, Merck & Co., Mylan N.V., Roche Diagnostics, Schering-Plough and Teva Pharmaceutical Industries Ltd.
Applications Covered:
-Hepatitis-B antivirals
-Hepatitis-C antivirals
-Herpes virus
-HIV antivirals
-Influenza
-Other Applications
-Pneumonia
-Flu
End-Users Covered:
-Ambulatory Surgical Centers
-Clinics
-Hospitals
Distribution Channels covered:
-Hospital Pharmacy Store
-Online Pharmacy
-Retail Pharmacy Store
Product Types Covered:
-Generic Drugs
-Branded Drugs
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001716560/sample
Action Mechanisms covered:
-Nucleotide polymerase inhibitor
-Protease inhibitors
-Reverse transcriptase inhibitors
-Other Action Mechanisms
Regions Covered:
-North America
-US
-Canada
-Mexico
-Europe
-Germany
-France
-Italy
-UK
-Spain
-Rest of Europe
-Asia Pacific
-Japan
-China
-India
-Australia
-New Zealand
-Rest of Asia Pacific
-Rest of the World
-Middle East
-Brazil
-Argentina
-South Africa
-Egypt
Company Profiling
12.1 Abbott Laboratories
12.2 AbbVie, Inc.
12.3 Aurobindo Pharma
12.4 Bristol-Myers-Squibb
12.5 Cipla
12.6 Dr. Reddy's Laboratories Ltd
12.7 F. Hoffmann-La Roche AG
12.8 Gilead Sciences
12.9 GlaxoSmithKline plc.
12.10 Johnson and Johnson
12.11 MedImmune/AstraZeneca
12.12 Merck & Co
12.13 Mylan N.V.
12.14 Roche Diagnostics
12.15 Schering-Plough
12.16 Teva Pharmaceutical Industries Ltd.
Inquire before Buying at http://www.reportsweb.com/inquiry&RW0001716560/buying
Contact Information:
ReportsWeb.com
Priya Sisodia
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsWeb.com
Priya Sisodia
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results